Alterations of the cytokine network in patients undergoing cardiopulmonary bypass

Perfusion

Volumn 12, Issue 6, 1997, Pages 393-403

  Sablotzki, A ^a   Dehne, M ^a   Welters, I ^a   Menges, T ^a   Lehmann, N ^a   Gorlach G ^a   Osmer, C ^a   Hempelmann, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 0030782643     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919701200608     Document Type: Article

References (44)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
3. Robb JR. Interleukin-2: the molecule and its function. Immunol Today 1984; 5: 203-208.
4. Wagasuki H, Bertoglio J, Tursz T, Fradelizi D. IL-2 receptor induction on human T lymphocytes: role for IL-2 and monocytes. J Immunol 1985; 135: 321-27.
5. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8: 253-78.
6. Sironi M, Breviario F, Proserpio P. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 237-39.
7. Holzheimer R, Molloy RG, Goerlach H, Wilkert S, Hehrlein FW. IL-6 and TNF-alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection 1994; 22: 37-42.
8. Kushner I, Rzewnicki DL. The acute phase response: General aspects. Baillière's Clin Rheumatol 1994; 8: 513-30.
9. Katsikis PD, Chu CQ, Brennan FH, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 (IL-10) in RA. J Exp Med 1994; 179: 1517-22.
10. Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann TR. Interleukin 10. Annu Rev Immunol 1993; 11: 165-90.
11. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
12. Hempel L, Korholz D, Bonig H. Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol 1995; 41: 462-66.
13. Wang P, Wu P, Siegel MI, Egan RW, Billak MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994; 153: 811-16.
14. Taga K, Tpsato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143-48.
15. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6: 597-641.
16. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 1989; 10: 258-61.
17. Assoian RK, Fluerdelys BE, Stevenson HC et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-23.
18. Lefer AH, Tsao P, Aoki N, Palladino MA. Mediation of cardioprotection by transforming growth factor-β. Science 1990; 249: 61-64.
19. Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-33.
20. Robertson MJ, Soiffer RJ, Wolf SF et al. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992; 175: 779-83.
21. Wenner CA, Güler ML, Macatonia SE, O'Garra A, Murphy KM. Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J Immunol 1996; 156: 1442-47.
22. Morris SC, Madden KB, Adamovicz JJ et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994; 152: 1047-56.
23. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53: 833-38.
24. Haeffner-Cavaillon N, Rousselier JM, Ponzio O. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 1100-106.
25. Kalfin RE, Engelmann RM, Rousou A. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 1993; 88: 401-406.
26. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 636-41.
27. Chu S-H, Hu R-H, Lu Y-C, Chun K-T. Changes in white blood cells, immunosuppressive acidic protein and interleukin-2 receptor after open heart surgery. Thorac Cardiovasc Surgeon 1995; 43: 94-98.
28. Furunaga A. Measurement of cytokines at cardiopulmonary bypass. Nippon Kyobu Geka Gakkai Zasshi 1994; 42: 2200-206.
29. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskan L. Changes in the plasma protease systems during open-heart surgery with dextran vs. ringer acetate as priming solution. Scand J Thor Cardiovasc Surg 1989; 23: 253-58.
30. Steinberg JB, Kapelanski DP, Olson JD, Weiler JH. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-16.
31. Menasche P, Haydar S, Paynet J, DuBuit C, Merval R. A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994; 107: 293-99.
32. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichardt B. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 1993; 105: 15-24.
33. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. Detection of interleukin-10 in patients with septic shock. Intensive Care Med 1994; 20(suppl 1): 9.
34. Chernoff AE, Granowitz EV, Shapiro L. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154: 5492-99.
35. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of Th 1 and Th 2 responses. Immunoparasitol Today 1991; 2: 49-53.
36. Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th 1 cells. J Immunol 1991; 146: 3444-48.
37. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-52.
38. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-76.
39. Wan S, Marchant A, DeSmet JM et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111: 469-77.
40. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578-82.
41. Warwick-Davies J, Lowrie DB, Cole PJ. Selective deactivation of human monocyte functions by TGF-β. J Immunol 1995; 155: 3186-93.
42. Sieling PA, Wang X-H, Gately MK et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994; 153: 3639-47.
43. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482-90.
44. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 1996; 156: 1196-206.